ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Broder Encourages Support Of Drug Development Programs

March 10, 1995

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

NCCN Publishes Anemia Guidelines

April 12, 2002

DCE Advisors Okay Contract Recompetitions For Epidemiology

November 18, 1994